menu
    • menu

    Company profile for Jasper Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Jasper TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3000 Sand Hill Road B1-145, Menlo Park, CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.jaspertherapeutics.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/jasperwealth
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jasper Therapeutics Hosts Investor Webinar On Asthma Study Data
    Jasper Therapeutics Hosts Investor Webinar On Asthma Study Data

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3197482/0/en/Jasper-Therapeutics-to-Host-an-Investor-Webinar-on-December-2nd-to-Present-Preliminary-Data-from-ETESIAN-Study-in-Asthma-and-Findings-from-BEACON-Study-Investigation.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Jasper Therapeutics Unveils Q3 2025 Financials & Corporate Update
    Jasper Therapeutics Unveils Q3 2025 Financials & Corporate Update

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184506/0/en/Jasper-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Jasper Therapeutics To Present At Upcoming Investor Conferences
    Jasper Therapeutics To Present At Upcoming Investor Conferences

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180250/0/en/Jasper-Therapeutics-to-Present-at-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share
    Jasper Therapeutics Price $30M Public Offering of Stock, Warrants
    Jasper Therapeutics Price $30M Public Offering of Stock, Warrants

    19 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/19/3153166/0/en/Jasper-Therapeutics-Announces-Pricing-of-30-Million-Public-Offering-of-Common-Stock-Pre-Funded-Warrants-and-Common-Warrants.html

    GLOBENEWSWIRE
    19 Sep 2025
    Share Share
    Jasper Pharma Proposes Public Offering of Stock and Warrants
    Jasper Pharma Proposes Public Offering of Stock and Warrants

    18 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/18/3152823/0/en/Jasper-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock-Pre-Funded-Warrants-and-Common-Warrants.html

    GLOBENEWSWIRE
    18 Sep 2025
    Share Share
    Jasper Therapeutics to Present at Upcoming Investor Conferences
    Jasper Therapeutics to Present at Upcoming Investor Conferences

    27 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/27/3140409/0/en/Jasper-Therapeutics-to-Present-at-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    27 Aug 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search